Related Experiment Videos
Persistent local cutaneous atrophy following corticosteroid injection for tendinitis
Rheumatology and Rehabilitation
|May 1, 1979
Summary
Local corticosteroid injections, like triamcinolone for tendinitis, can cause localized skin atrophy. This side effect may show partial remission over time, highlighting the importance of monitoring treatment outcomes.
Area of Science:
- Dermatology
- Rheumatology
- Sports Medicine
Background:
- Corticosteroids are frequently used for localized inflammatory conditions, such as tendinitis.
- Triamcinolone is a common corticosteroid for intra-articular and soft tissue injections.
- Potential adverse effects of local steroid injections require careful consideration.
Observation:
- A 21-year-old female patient received triamcinolone injections for forearm oblique muscle tendinitis.
- The patient developed localized skin atrophy at the injection sites.
- Skin changes were monitored for over five years.
Findings:
- Localized skin atrophy is a potential adverse effect of triamcinolone injections.
- Partial remission of steroid-induced skin atrophy can occur over an extended period.
- The study provides a synopsis of local steroid use for diverse medical conditions.
Implications:
- Clinicians should be aware of the risk of skin atrophy with local corticosteroid therapy.
- Long-term monitoring may be necessary for patients experiencing steroid-induced skin changes.
- Understanding the risk-benefit profile of local steroid injections is crucial for patient management.